Browsing by Author "Tur, BS"

Now showing 1 - 6 of 6
  • No Thumbnail Available
    Item
    Pulmonary rehabilitation principles in SARS-COV-2 infection (COVID-19): The revised guideline for the acute, subacute, and post-COVID-19 rehabilitation
    Aytür, YK; Köseoglu, BF; Taskiran, ÖÖ; Ordu-Gökkaya, NK; Delialioglu, SÜ; Tur, BS; Sarikaya, S; Sirzai, H; Tiftik, TT; Alemdaroglu, E; Ayhan, FF; Çakit, BDD; Genç, A; Gündogdu, I; Güzel, R; Karayel, DD; Kaya, BB; Öken, Ö; Özdemir, H; Soyupek, F; Tikiz, C
    Coronavirus disease 2019 (COVID-19) is a contagious infection disease, which may cause respiratory, physical, psychological, and generalized systemic dysfunction. The severity of disease ranges from an asymptomatic infection or mild illness to mild or severe pneumonia with respiratory failure and/or death. COVID-19 dramatically affects the pulmonary system. This clinical practice guideline includes pulmonary rehabilitation (PR) recommendations for adult COVID-19 patients and has been developed in the light of the guidelines on the diagnosis and treatment of COVID-19 provided by the World Health Organization and Republic of Turkey, Ministry of Health, recently published scientific literature, and PR recommendations for COVID-19 regarding basic principles of PR. This national guideline provides suggestions regarding the PR methods during the clinical stages of COVID-19 and post-COVID-19 with its possible benefits, contraindications, and disadvantages.
  • No Thumbnail Available
    Item
    Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism
    Ataman, S; Borman, P; Evcik, D; Aydog, E; Ayhan, F; Yildizlar, D; Bodur, H; Altay, Z; Birtane, M; Bütün, B; Duruöz, T; Erdem, HR; Gunendi, Z; Günaydin, R; Gürer, G; Kaçar, C; Kaptanoglu, E; Kaya, T; Ölmez, N; Paker, N; Rezvani, A; Tur, BS; Yener, M; Özgöçmen, S
    Objectives: Taking new developments in the management of rheumatoid arthritis (RA) and the economic conditions of our country into account, the Turkish League Against Rheumatism (TLAR) aimed to develop national treatment recommendations for the management of RA; thus, they consulted with national experts for their opinions. Materials and methods: Eight rheumatologists and 15 physiatrists experienced in the field contributed to the development of the TLAR recommendations for the management of RA. The expert committee planned to develope Recommendations for the Management of RA in Turkey based on EULAR 2010 recommendations for the management of RA with synthetic and biological disease-modifying antirheumatic drugs (DMARDs) in light of expert opinions. Following the meeting, a systematic literature review was performed by searching the Medline and Cochrane, Embase, and Turkish Medical Index databases between 2009 and 2010 for pharmacological treatment recommendations and between 2007 and 2010 for non-pharmacological treatment recommendations. This was done in addition to the studies included in the EULAR 2010 recommendations. All articles were examined, their contents were summarized, their levels of evidence were determined, and the Delphi process was initiated. Results: Sixteen general recommendations were listed along with five main principles and one non-pharmacological treatment method. A consensus was reached for all recommendations, and their strength levels were voted upon. Conclusion: Recommendations were formed for the management of RA in Turkey. These national recommendations are intended to guide physical medicine and rehabilitation specialists (physiatrists), rheumatologists, and family physicians and should be regularly updated.
  • No Thumbnail Available
    Item
    Applying the WHO ICF framework to long COVID patients with persistent respiratory symptoms
    Köseoglu, BF; Tur, BS; Gökkaya, NKO; Gökmen, IG; Kesiktas, FN; Kaya, BB; Önal, R; Tuncay, F; Genç, A; Findikoglu, G; Dogan, SK; Sütbeyaz, ST; Sarikaya, S; Tikiz, C; Özdemir, H; Kabayel, DD; Atar, MO; Atan, T; Selcen, Y
    Objectives: The aim of this study was to evaluate long COVID patients with persistent respiratory symptoms through the application of the World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) framework.Patients and methods: This national, prospective, multicenter, cross-sectional study was conducted with 213 patients (118 females, 95 males; median age 56 years; range, 20 to 85 years) with long COVID between February 2022 and November 2022. The ICF data were primarily collected through patient interviews and from the acute medical management records, physical examination findings, rehabilitation outcomes, and laboratory test results. Each parameter was linked to the Component Body Functions (CBF), the Component Body Structures (CBS), the Component Activities and Participation (CAP), the Component Environmental Factors (CEF), and Personal Factors according to the ICF linking rules. Analysis was made of the frequency of the problems encountered at each level of ICF category and by what percentage of the patient sample.Results: In the ICF, 21 categories for CBF, 1 category for CBS, and 18 categories of CAP were reported as a significant problem in a Turkish population of long COVID patients with persistent respiratory symptoms. Furthermore, eight categories for CEF were described as a facilitator, and four as a barrier.Conclusion: These results can be of guidance and provide insight into the identification of health and health-related conditions of long COVID patients with persistent respiratory symptoms beyond the pathophysiological aspects, organ involvement, and damage of COVID-19. The ICF can be used in patients with long COVID to describe the types and magnitude of impairments, restrictions, special needs, and complications.
  • No Thumbnail Available
    Item
    COVID-19, cardiac involvement and cardiac rehabilitation: Insights from a rehabilitation perspective - State of the Art
    Tur, BS; Köseoglu, BF; Gökkaya, NKO; Aytür, YK; Taskiran, ÖÖ; Kabayel, DD; Kesiktas, N; Tikiz, C; Özdemir, H; Alemdaroglu, E; Kaya, BB; Genç, A; Sütbeyaz, ST
    Since the beginning of the pandemic, many novel coronavirus disease 2019 (COVID-19) patients have experienced multisystem involvement or become critically ill and treated in intensive care units, and even died. Among these systemic effects, cardiac involvement may have very important consequences for the patient's prognosis and later life. Patients with COVID-19 may develop cardiac complications such as heart failure, myocarditis, pericarditis, vasculitis, acute coronary syndrome, and cardiac arrhythmias or trigger an accompanying cardiac disease. The ratio of COVID-19 cardiac involvement ranges between 7 and 28% in hospitalized patients with worse outcomes, longer stay in the intensive care unit, and a higher risk of death. Furthermore, deconditioning due to immobility and muscle involvement can be seen in post-COVID-19 patients and significant physical, cognitive and psychosocial impairments may be observed in some cases. Considering that the definition of health is a state of complete physical, mental and social well-being, individuals with heart involvement due to COVID-19 should be rehabilitated by evaluating all these aspects of the disease effect. In the light of the rehabilitation perspective and given the increasing number of patients with cardiac manifestations of COVID-19, in this review, we discuss the rehabilitation principles in this group of patients.
  • No Thumbnail Available
    Item
    Evidence-Based Recommendations for the Management of Knee Osteoarthritis: A Consensus Report of the Turkish League Against Rheumatism
    Tuncer, T; Çay, HF; Kaçar, C; Altan, L; Atik, OS; Aydin, AT; Ayhan, FF; Yanik, BÇ; Durmaz, B; Eskiyurt, N; Genç, H; Kutsal, YG; Günaydin, R; Hepgüler, S; Hizmetli, S; Kaya, T; Kurtais, Y; Ölmez, N; Saridogan, M; Sindel, D; Tur, BS; Sütbeyaz, S; Sendur, ÖF; Ugurlu, H; Ünlü, Z
    Objectives: Knee osteoarthritis (OA) is a common disease which causes pain, disability and great socioeconomic burden as a result. Turkish League Against Rheumatism (TLAR) initiated a project to prepare national, evidence-based recommendations for the management of knee osteoarthritis supported by expert-opinion in order to assist the physicians who are interested in knee OA in their daily clinical practice. Materials and methods: The expert committee was composed of 25 academicians, 23 of whom were physical medicine and rehabilitation (PM&R) specialists (three also had rheumatology subspeciality) and two were orthopedic surgeons. At the first meeting, the previous guidelines were discussed, and 2008 Osteoarthritis Research Society International (OARSI) recommendations were decided to be taken as the fundamental template for national recommendations. Databases of the Pubmed, Embase, Cochrane, and Turkish Medical Index were used to search the literature, and this was carried out for the period between 2009-2010 for international publications since studies up to 2009 were present in the 2010 OARSI update. No limit was applied for searching of national publications. The selected relevant publications were graded according to evidence level and quality, and were sent to the members who were then asked to suggest propositions according to their experiences, knowledge, and review of the literature. After amalgamation and editing of new proposals, Delphi rounds were started. After five Delphi rounds, the propositions on which the members were in consensus, were discussed with regard to evidence and the strength of recommendation was determined by measuring on visual analog scale (VAS) for each proposal at the final meeting. Results: Nineteen propositions (one for general principles, nine for non-pharmacologic treatments, seven for pharmacologic treatments, and two for surgical treatments) were accepted as the TLAR Evidence-Based Recommendations for the Management of Knee OA in consensus as a result of Delphi rounds. Conclusion: Evidence-based recommendations for the management of knee OA were developed by TLAR for the first time in our country. The recommendations should be updated regularly according to new evidence and insights. It is expected that physicians who are interested in knee OA will benefit greatly from this report in their daily clinical practice.
  • No Thumbnail Available
    Item
    Evaluation of the physical and emotional effects of the COVID-19 pandemic on patients with fibromyalgia and chronic low back pain: A multicenter cross-sectional controlled study
    Bagcier, F; Kibar, S; Evcik, D; Ketenci, A; Sindel, D; Tur, BS; Ünlü, Z; Tikiz, C; Keskin, D; Alp, A; Ay, S; Yanik, B; Külcü, DG; Karakas, M; Nazlikul, FGU; Oktay, KNK; Aksoy, MK; Findikoglu, G; Eser, F; Atici, A; Yurdakul, OV; Koçak, FA; Kurt, EE; Özkan, Y; Dogan, SK; Sultanoglu, TE; Ordahan, B; Umay, EK; Demirhan, E; Yagci, HC; Balbaloglu, Ö; Tezel, N; Satis, S; Atar, S; Akaltun, MS
    Objectives: This study aimed to investigate the physical and emotional effects of the coronavirus disease 2019 pandemic in patients with fibromyalgia syndrome (FMS) and chronic low back pain (CLBP) patients. Patients and methods: The cross-sectional controlled study was performed with 1,360 participants (332 males, 1,028 females; mean age: 42.3 +/- 12.5 years; range, 18 to 65 years) between September 2020 and February 2021. The participants were evaluated in three groups: the FMS group (n=465), the CLBP group (n=455), and the healthy control group (n=440). Physical activity, pain levels, and general health status before and during the pandemic were evaluated in all participants. Stress levels were analyzed with the perceived stress scale (PSS) in all groups, and disease activity was analyzed with the fibromyalgia impact questionnaire (FIQ) in patients with FMS. Results: Patients with FMS had worsened general health status and pain levels during the pandemic compared to the other groups (p<0.01). The FMS group showed significantly higher PSS scores than those in other groups (p<0.01). There was a weak-positive correlation between FIQ and PSS parameters in patients with FMS (p<0.05, r= 0.385). Conclusion: The general health status, pain, and stress levels of the patients with FMS and CLBP tended to worsen during the pandemic. This high-stress level appeared to affect disease activity in patients with FMS.